Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes-Reference-Cited by-同舟云学术

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes

Published:2014-09-19 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Jones Siân,Stransky Nicolas,McCord Christine L.,Cerami Ethan,Lagowski James,Kelly Devon,Angiuoli Samuel V.,Sausen Mark,Kann Lisa,Shukla Manish,Makar Rosemary,Wood Laura D.,Diaz Luis A.,Lengauer Christoph,Velculescu Victor E.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms6006.pdf

Reference70 articles.

1. Jin, Z. et al. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis. Int. J. Gynecol. Pathol. 22, 368–373 (2003).

2. El-Nashar, S. A. & Mariani, A. Uterine carcinosarcoma. Clin. Obstet. Gynecol. 54, 292–304 (2011).

3. Ahuja, A., Safaya, R., Prakash, G., Kumar, L. & Shukla, N. K. Primary mixed mullerian tumor of the vagina--a case report with review of the literature. Pathol. Res. Pract. 207, 253–255 (2011).

4. Sharma, N. K., Sorosky, J. I., Bender, D., Fletcher, M. S. & Sood, A. K. Malignant mixed mullerian tumor (MMMT) of the cervix. Gynecol. Oncol. 97, 442–445 (2005).

5. Duman, B. B., Kara, I. O., Gunaldi, M. & Ercolak, V. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. Arch. Gynecol. Obstet. 283, 1363–1368 (2011).

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and molecular features of tubo-ovarian carcinosarcomas: a series of 51 cases;Frontiers in Oncology;2024-08-22

2. Research progress of SWI/SNF complex in breast cancer;Epigenetics & Chromatin;2024-02-17

3. Molecular profile of bladder cancer progression to clinically aggressive subtypes;Nature Reviews Urology;2024-02-06

4. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications;International Journal of Molecular Sciences;2024-01-15

5. Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas;Pathology and Oncology Research;2023-12-11